Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Hemostasis/cooling blood/stabilizing vessels" via hemostatic herbs/traditional mechanisms does not refer to a single molecule or receptor but rather describes a physiological process involving the coordinated action of blood vessels, platelets, and plasma proteins to stop bleeding after vascular injury[1][3][5]. Hemostasis consists of three main steps: 1. Vasoconstriction: Immediate narrowing of the damaged vessel to reduce blood flow. 2. Platelet plug formation: Platelets adhere to exposed collagen at the injury site and aggregate to form a temporary seal[5][9]. 3. Coagulation: Activation of clotting factors leads to conversion of fibrinogen into fibrin strands that stabilize the platelet plug[1][5]. Traditional herbal medicines may promote hemostasis through various mechanisms such as stimulating vasoconstriction, enhancing platelet aggregation, activating coagulation pathways (including factor XII and fibrinogen), or inhibiting fibrinolysis[2][4][6]. The active compounds in these herbs include tannins, flavonoids, alkaloids and other phytochemicals that can act on different components within this complex system. Because "hemostasis" is not a discrete molecular target but an integrated biological response involving many molecules—such as receptors on platelets and endothelial cells; enzymes like thrombin; structural proteins like fibrinogen; and regulatory factors—this entry is considered incorrect for use as a canonical therapeutic target. Instead, individual components within the hemostatic pathway should be specified for structured data purposes. If you are seeking information about specific molecular targets involved in herbal modulation of hemostasis—such as "Factor XII," "Thrombin," or "Platelet glycoprotein IIb/IIIa receptor"—those should be listed individually rather than using this broad physiological term[2][4].
Inhibition or activation of coagulation factors
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemostasis system.